The New York Times (5/16, Rabin) reports that an “online survey of nearly 1,800 American women found that in the early days of the pandemic, fear of childbirth, “may have affected the majority of American women: 62% of pregnant respondents reported high levels of fear and worry about childbirth.” The survey indicated that “more than 80% of the women said that because of the pandemic, they were worried that they would not have the support person they wanted in the hospital with them while in labor, that their baby might be taken away if they were diagnosed with COVID or that they might infect their baby if they had the virus.” Meanwhile, “Black mothers, who face almost three times the risk of dying from pregnancy-related complications, were” nearly “twice as likely to have a strong fear of childbirth as white mothers.” The findings were published in Evolution, Medicine, and Public Health.

Related Links:

— “Many Women Have an Intense Fear of Childbirth, Survey Suggests “Roni Caryn Rabin, The New York Times, May 16, 2023

Psychiatric News (5/16) reports, “Older adults who use the internet regularly have nearly half the risk of dementia as adults with limited internet use,” according to findingspublished online May 3 in the Journal of the American Geriatrics Society. The study, which “included 18,154 adults aged 50 to 64 who did not have dementia at baseline and who responded to at least one survey between 2002 and 2016,” also indicated that “the more years of regular internet use, the more pronounced the anti dementia benefits become.”

Related Links:

— “Regular Internet Use May Lower Dementia Risk in Older Adults, Psychiatric News, May 16, 2023

Healio (5/16, VanDewater) reports, “Among people with depression, the most common reasons for hospitalization were physical conditions rather than psychiatric ones,” investigators concluded in findingspublished online May 3 in JAMA Psychiatry. After analyzing “data from the U.K. Biobank, the Finnish Health and Social Support Study” and “the Finnish Public Sector Study…to identify associations between self-reported or physician-diagnosed depression and reason for hospitalization,” the study team found not only that “people with depression were most likely to be hospitalized for an endocrine, musculoskeletal or vascular disease,” but also that depression was associated “to the progression of heart disease and diabetes.”

Related Links:

— “People with depression commonly hospitalized for physical medical conditions “Kalie VanDewater, Healio, May 16, 2023

Reuters (5/16, Heavey) reports, “The Biden administration is seeking to meet with the makers of the life-saving medication naloxone used to reverse opioid overdoses in an effort to increase access and reduce cost, a spokesperson for the White House Office of National Drug Control Policy” (ONDCP) announced. ONDCP Director Dr. Rahul Gupta “‘plans to have conversations with manufacturers to share his key principle moving forward: the easier it is for people to access naloxone, the more lives we can save,’ the spokesperson said.”

Related Links:

— “White House wants to improve access to opioid overdose reversal medication “Susan Heavey, Reuters, May 16, 2023

The New York Times (5/15, Kolata) reports that researchers have discovered a genetic mutation in one patient that appears to delay Alzheimer’s disease from entering the patient’s entorhinal cortex, even though brain scans “revealed severe atrophying and…rough, hard, amyloid plaques and spaghetti-like tangles of tau proteins.” This particular “mutation results in a potent version of a protein, Reelin, in the entorhinal cortex,” and this “super-potent Reelin ultimately prevents tangled strands of tau proteins from sticking together and forming the structures that are a characteristic of Alzheimer’s.” The discovery has prompted researchers to investigate this as a potential target in developing the next generation of Alzheimer’s therapeutics. The findings of the research were published in Nature Medicine.

The Washington Post (5/15, A1, Johnson) reports that “this man is only the second patient identified with the miraculous ability to defy the devastating Alzheimer’s gene.” A previously known patient with a different mutation also had a brain “clogged with the characteristic amyloid plaques of Alzheimer’s, [but] it was relatively free of the tangles of tau that are also associated with the disease.” Investigators “did find an overlap between the two different gene mutations that helped protect these individuals: Both mutations affect proteins that bind to the same receptors on the surfaces of brain cells.”

Related Links:

— “Mutation Protected Man From Alzheimer’s Disease, Hinting at Treatment “Gina Kolata, The New York Times, May 15, 2023